logo

Takeda Pharmaceutical Company Limited (TAK)



Trade TAK now with
  Date
  Headline
9/20/2022 8:05:01 AM Canada Approves Takeda's LIVTENCITY For Treatment Of Adults With Post-transplant Cytomegalovirus Infection
9/16/2022 8:07:11 AM Takeda Gets Positive CHMP Opinion For Maribavir For Treatment Of Adults With Post-transplant CMV Refractory
9/14/2022 8:01:54 AM Takeda Announces National Launch Of CDPATH Program
9/7/2022 8:00:58 AM Takeda Canada Partners With The Canadian Institutes Of Health Research To Advance Research In Rare Diseases
8/22/2022 10:01:03 AM Takeda's Dengue Vaccine QDENGA Approved In Indonesia
7/28/2022 3:16:27 AM Takeda Pharma Q1 EPS 68 Yen; Core EPS 145 Yen
7/21/2022 8:06:31 AM Takeda Announces Positive Topline Results From Pivotal Phase 3 Clinical Trial Of HYQVIA
7/20/2022 8:48:36 AM F-star Therapeutics Enters License Deal With Takeda To Develop Bispecific Antibody
6/27/2022 6:03:05 AM Takeda Publishes Results From Phase 2 Study Of Fazirsiran In New England Journal Of Medicine
6/22/2022 6:59:06 AM Takeda Inks 15-year Lease With BioMed Realty For R&D And Office Space To Be Built In Kendall Square
6/9/2022 4:34:17 AM Takeda Says Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Thro 4.5 Yrs In Clinical Trial
6/7/2022 11:03:10 AM Takeda Canada Welcomes Quebec's New Rare Disease Policy